Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15  months. Recent molecular characterization studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar A. Mujeeb, Michael R. Olin, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein, Maria G. Castro
Formato: Artículo
Lenguaje:English
Publicado: Frontiers Media S.A. 2021-05-01
Colección:Frontiers in Pharmacology
Materias:
immunosuppression
inflammation
tumor microenvironment
glioma
immunotherapy
Acceso en línea:https://www.frontiersin.org/articles/10.3389/fphar.2021.680021/full

Ejemplares similares

Ejemplares similares